Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Lilly prepares potent and orally active thrombin inhibitors

May 25, 2000

Neutralase studied in percutaneous coronary intervention trial

May 23, 2000

FDA denies approval for Refludan in acute coronary syndrome

May 19, 2000

Genzyme Transgenics and Genzyme General receive orphan drug designation

May 18, 2000

Eryloside F: a new thrombin receptor antagonist produced by a marine sponge

May 17, 2000

Glaxo Wellcome reveals recent findings in its thrombin inhibitor program

May 17, 2000

Pharmacological profile of SL-650472, a novel antiplatelet, antithrombotic agent

May 15, 2000

Antiplatelet effects of green tea and a major component discussed in Porto

May 12, 2000

New antiplatelet agents with pyrrolidinone structure described by Boehringer Ingelheim

May 12, 2000

Investigational anticoagulant H-376/95/melagatran given wide coverage at recent congress

May 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...